A capsule containing total flavonoids of Desmodium styracifolium, a method for preparing the same and a use of the capsule containing total flavonoids of Desmodium styracifolium are provided. Specifically, the capsule includes total flavonoids of Desmodium Styracifolium provided in a form of alcohol extract of Desmodium Styracifolium and a pharmaceutically acceptable excipient.

An external skin preparation containing an edelweiss extract, and one or more extracts selected from the group consisting of extracts of plants belonging to the genus Artemisia, pipsissewa extract, olive extract, jojoba extract, carambola extract, clove extract, chamomile extract, carrot extract, daisy extract, peach kernel extract, marsh mallow extract, cinnamon bark extract, told extract, marigold extract, parsley extract, coltsfoot extract, creeping saxifrage extract and European elderberry extract.

The present invention includes a method of using PHY906 for treating a bowel disorder including inflammatory bowel disease and irritable bowel syndrome. Particularly, the present invention provides a multiple symptoms treatment for the bowel disorder.

A method is disclosed for providing treatment with cannabis to treat insomnia, anxiety, or seizure, among others.

The invention relates to a soybean seed extract, method for producing the same and uses of the extract of soybean seeds in promoting wound healing, promoting neuron cell proliferation and/or treating brain diseases and/or neurodegenerative diseases, treating breast cancer, reducing side effects of interfering with DNA and/or RNA replication drugs and/or enhancing pharmaceutical effects of interfering with DNA and/or RNA replication drugs.

The invention relates to a particular cosmetic active substance that is constituted through bioconversion by Lactobacillus arizonensis of its original substrate, Simmondisia chinens. The invention also relates to a preparation method, to compositions comprising same, and to uses thereof for cosmetic applications.

The subject matter of the present invention is the use of chitin or a derivative of chitin for preventing and/or treating parasitoses, and in particular cryptosporidiosis. The present invention also pertains to a composition that comprises at least one base agent chosen from among chitin or a derivative of chitin and at least one secondary agent chosen from among an agent for stimulating immunity and an antiparasite agent, as well as the use of same for preventing and/or treating parasitoses, in particular cryptosporidiosis.

This invention provides solid substrates for mitigating or preventing cell or tissue adherence and/or vascularization, which solid substrates comprise a marine organism skeletal derivative and are characterized by a specific fluid uptake capacity value of less than 40%, processes for selection of the same and applications of the same. This invention also provides solid substrates for mitigating or preventing cell or tissue adherence and/or vascularization, which solid substrates are characterized by having a contact angle value of more than 60 degrees, when in contact with a fluid. This invention also provides solid substrates for mitigating or preventing cell or tissue adherence and/or vascularization, which solid substrate is characterized by a minimal surface roughness (Ra) or substantial surface smoothness, as measured by scanning electron microscopy or atomic force microscopy. The invention also provides processes for selection of an optimized coral-based solid substrate.

The present invention relates to a synergistic extract of Palmaria palmata and of jasmine flower heads, obtained after aqueous extraction of Palmaria palmata, in which maceration of the jasmine flower heads is then carried out, the ratio of the dry weight of Palmaria palmata to the dry weight of the flower heads being between 40/60 and 95/5. The present invention also relates to a method for obtaining said synergistic extract and cosmetic compositions comprising said extract as an active agent. The invention finally relates to the cosmetic use of said composition for combating the signs of aging and for improving the elasticity of the skin, by favoring maintenance of the “stem” character of the adult dermal stem cells (SKPs).

This invention relates to use of pharmaceutical compositions in preparing pharmaceuticals for treating diabetic ulcer in limb or on body surface, or in preparing medical dressing. The pharmaceutical compositions consist of (A) 3 to 15% by weight of edible beeswax and (B) 85 to 97% by weight of sesame oil extract of Huangqin, Huanglian, Huangbai, earthworm and poppy capsule, based on the total weight of the pharmaceutical compositions. In the sesame oil extract, each of Huangqin, Huanglian, Huangbai, earthworm and poppy capsule is in an amount of 2 to 10% by weight of dry raw material based on the total weight of sesame oil. This invention also relates to a medical dressing for treating diabetic ulcer and corresponding medicine box enclosing the said dressing.